From: Video-telecare collaborative pain management during COVID-19: a single-arm feasibility study
VCPM patient characteristics | n (%) or mean (SD) |
---|---|
Gender, n (%) | |
Male | 42 (95.5) |
Female | 2 (4.5) |
Age, mean (SD) | 63.5 (8.5) |
Rural, n (%) | 24 (54.5%) |
Race/Ethnicity, n (%) | |
Black | 3 (6.8) |
White | 38 (86.4) |
Other | 3 (6.8) |
Ethnicity, n (%) | |
Hispanic or Latino | 11 (25.6) |
Pain Generator, n (%) | |
Back Pain | 38 (86.3) |
Fibromyalgia | 2 (4.5) |
Neck Pain | 16 (36.3) |
Osteoarthritis | 26 (59.1) |
Neuropathic Pain | 15 (34.1) |
Headache | 9 (20.5) |
Other MSK | 25 (56.8) |
Other Rheumatological | 8 (18.2) |
Comorbidities, n (%) | |
RIOSORD Comorbidity | 40 (90%) |
Substance Use Disorder | 11 (25%) |
Mental Health Disorder | 22 (50%) |
Morphine equivalent daily dose, mean (SD) | 117.3 (100.3) |
Location, n (%) | |
VA Connecticut Healthcare System | 17 (38.6) |
VA Eastern Colorado Health Care System | 27 (61.4) |